Search

Search Constraints

You searched for: Author/Creator Finn, S.

Search Results

4. 56: Multiple RTK targeting as a therapeutic option in malignant pleural mesothelioma. (January 2017)

7. ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. (December 2019)

8. Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development. Issue 2 (February 2015)

10. The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study. Issue 1 (1st January 2020)